June 2026
1. MCGUIGAN A
   Zoliflodacin: First Approval.
   Drugs. 2026;86:963-970.
   

   >> Share

   
   April 2026
2. GU Q, Chen Y, Ding P, He J, et al
   Antifungal Treatment Regimens as Primary Therapy for Invasive Aspergillosis: A Systematic Review and Network Meta-analysis.
   Drugs. 2026 Apr 21. doi: 10.1007/s40265-026-02316.
   

   >> Share

   
   January 2026
3. SHIRLEY M
   Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms.
   Drugs. 2026;86:79-91.
   

   >> Share

   
   November 2025
4. KEAM SJ
   Gepotidacin: First Approval.
   Drugs. 2025;85:1479-1485.
   

   >> Share

   
   March 2025
5. FUNG S, Shirley M
   Rezafungin: A Review in Invasive Candidiasis.
   Drugs. 2025;85:415-423.
   

   >> Share

   
   
6. HEIMANN D, Kohnhauser D, Kohnhauser AJ, Bronstrup M, et al
   Antibacterials with Novel Chemical Scaffolds in Clinical Development.
   Drugs. 2025;85:293-323.
   

   >> Share

   
   January 2025
7. IOVLEVA A, Fowler VG Jr, Doi Y
   Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections.
   Drugs. 2025;85:21-40.
   

   >> Share

   
   December 2024
8. RAUCH A, Kohler N, Brehm TT, Zielinski N, et al
   Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis.
   Drugs. 2024 Dec 29. doi: 10.1007/s40265-024-02122.
   

   >> Share

   
   
9. CHIHOTA V, Gombe M, Gupta A, Salazar-Austin N, et al
   Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.
   Drugs. 2024 Dec 28. doi: 10.1007/s40265-024-02131.
   

   >> Share

   
   
10. SCHELLONG P, Joean O, Pletz MW, Hagel S, et al
    Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis.
    Drugs. 2024 Dec 25. doi: 10.1007/s40265-024-02135.
    

    >> Share

    
    
11. HIDALGO-TENORIO C, Bou G, Oliver A, Rodriguez-Aguirregabiria M, et al
    The Challenge of Treating Infections Caused by Metallo-beta-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
    Drugs. 2024;84:1519-1539.
    

    >> Share

    
    June 2024
12. KEAM SJ
    Cefepime/Enmetazobactam: First Approval.
    Drugs. 2024;84:737-744.
    

    >> Share

    
    March 2024
13. BLAIR HA
    SER-109 (VOWST()): A Review in the Prevention of Recurrent Clostridioides difficile Infection.
    Drugs. 2024;84:329-336.
    

    >> Share

    
    
14. SHIRLEY M
    Vonoprazan: A Review in Helicobacter pylori Infection.
    Drugs. 2024;84:319-327.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share